• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清学和超声检查指标对卵巢癌患者的治疗决策是否有用?

Could serologic and ultrasonographic indexes be useful for therapeutic decisions in patients with ovarian cancer?

作者信息

Achimaş-Cadariu P, Irimie Al, Achimaş-Cadariu L, Neagoe I, Buiga R

机构信息

University of Medicine and Pharmacy "Iuliu Hatieganu" Cluj-Napoca, Institute of Oncology "Prof. Dr. Ion Chiricuta" Cluj-Napoca, Romania.

出版信息

Chirurgia (Bucur). 2009 May-Jun;104(3):287-93.

PMID:19601460
Abstract

UNLABELLED

The objective of this study is to assess and quantify a relationship between different categories of prognostic factors in ovarian cancer, to establish patterns that explain the aggressiveness of some tumors, as well as to consider the above mentioned issues with regard to therapy decisions.

MATERIAL AND METHODS

This prospective observational and analytical research comprised 124 cases. The following were calculated: descriptive statistics, statistical comparisons, linear and multiple regressions, survival calculations, for clinical, serological, ultrasonographic, biological and temporal variables. In addition, new prognostic indexes were introduced.

RESULTS

A significant difference was found between well known predictors for evolution of ovarian cancer in the malignant and benign groups: Platelet Derived Endothelial Cell Growth Factor (PDECGF) p=0.0001; CA125 p=0.0027. Potential ultrasonographic and serologic predictors for malignity of ovarian masses were identified. Only two ultrasonographic predictors: Multilocular Solid Masses insight the tumor and Diastolic Notch fulfilled the required values in order to be considered independent predictors for disease free interval. High level correlation between serologic and ultrasonographic predictors was calculated; significant correlation between preoperative and postoperative vascular indexes was demonstrated.

DISCUSSIONS

The results suggest the possibility of therapy in ovarian cancer patients adjusted also to the angiogenic component of the disease.

摘要

未标注

本研究的目的是评估和量化卵巢癌不同类别预后因素之间的关系,建立能够解释某些肿瘤侵袭性的模式,并在治疗决策方面考虑上述问题。

材料与方法

这项前瞻性观察性和分析性研究纳入了124例病例。对临床、血清学、超声、生物学和时间变量进行了描述性统计、统计比较、线性和多元回归、生存计算。此外,还引入了新的预后指标。

结果

在恶性和良性组中,卵巢癌进展的已知预测因素之间存在显著差异:血小板衍生内皮细胞生长因子(PDECGF)p = 0.0001;CA125 p = 0.0027。确定了卵巢肿块恶性的潜在超声和血清学预测因素。只有两个超声预测因素:肿瘤内多房实性肿块和舒张期切迹满足所需值,才能被视为无病间期的独立预测因素。计算了血清学和超声预测因素之间的高度相关性;术前和术后血管指数之间存在显著相关性。

讨论

结果表明,卵巢癌患者的治疗有可能也根据疾病的血管生成成分进行调整。

相似文献

1
Could serologic and ultrasonographic indexes be useful for therapeutic decisions in patients with ovarian cancer?血清学和超声检查指标对卵巢癌患者的治疗决策是否有用?
Chirurgia (Bucur). 2009 May-Jun;104(3):287-93.
2
Preoperative serum vascular endothelial growth factor levels: significance in ovarian cancer.术前血清血管内皮生长因子水平:在卵巢癌中的意义
Clin Cancer Res. 2002 Oct;8(10):3193-7.
3
[Retrospective study of 167 ovarian tumors].167例卵巢肿瘤的回顾性研究
Tunis Med. 1999 Nov;77(11):551-7.
4
Studies on angiogenesis in the benign and malignant ovarian neoplasms with the use of color and pulsed Doppler sonography and serum CA-125, CA-19.9, CA-72.4 and vascular endothelial growth factor measurements.利用彩色和脉冲多普勒超声以及血清CA - 125、CA - 19.9、CA - 72.4和血管内皮生长因子测量对良性和恶性卵巢肿瘤血管生成的研究。
Ann Univ Mariae Curie Sklodowska Med. 2002;57(1):113-31.
5
[Correlation of preoperative serum vascular endothelial growth factor level with CA125 level in patients with epithelial ovarian cancer and its prognostic value].[上皮性卵巢癌患者术前血清血管内皮生长因子水平与CA125水平的相关性及其预后价值]
Zhonghua Fu Chan Ke Za Zhi. 2008 Jan;43(1):9-12.
6
A novel diagnostic index combining HE4, CA125 and age may improve triage of women with suspected ovarian cancer - An international multicenter study in women with an ovarian mass.一种结合人附睾蛋白4(HE4)、癌抗原125(CA125)和年龄的新型诊断指标可能改善疑似卵巢癌女性的分诊——一项针对有卵巢肿物女性的国际多中心研究。
Gynecol Oncol. 2015 Sep;138(3):640-6. doi: 10.1016/j.ygyno.2015.06.021. Epub 2015 Jun 16.
7
CA125 level as a predictor of progression-free survival and overall survival in ovarian cancer patients with surgically defined disease status prior to the initiation of intraperitoneal consolidation therapy.在接受腹腔巩固治疗前经手术确定疾病状态的卵巢癌患者中,CA125水平作为无进展生存期和总生存期的预测指标。
Gynecol Oncol. 2007 Jan;104(1):176-80. doi: 10.1016/j.ygyno.2006.07.027. Epub 2006 Sep 25.
8
Serial determinations of aminoterminal propeptide of type III procollagen (PIIINP) and prognosis in ovarian cancer; comparison to CA125.III型前胶原氨基端前肽(PIIINP)的系列测定与卵巢癌预后;与CA125的比较
Anticancer Res. 2000 Nov-Dec;20(6C):4655-60.
9
Discrimination between benign and malignant adnexal masses by specialist ultrasound examination versus serum CA-125.通过专业超声检查与血清CA-125鉴别附件良恶性肿块
J Natl Cancer Inst. 2007 Nov 21;99(22):1706-14. doi: 10.1093/jnci/djm199. Epub 2007 Nov 13.
10
Pre-operative prediction of serum CA125 level in women with ovarian masses.卵巢肿块女性血清CA125水平的术前预测
J Med Assoc Thai. 2007 Oct;90(10):1986-91.

引用本文的文献

1
Diagnostic Value of Nonacid Nucleic Blood Tumor Marker Panels in Early Diagnosing Breast Cancer: A Systematic Review and Network Meta-Analysis.非酸性核酸血液肿瘤标志物联合检测对早期诊断乳腺癌的诊断价值:系统评价和网络荟萃分析。
Dis Markers. 2022 Feb 3;2022:4119345. doi: 10.1155/2022/4119345. eCollection 2022.